Chest tube clogging after thoracic surgery is a common problem. When chest tubes clog with clot, blood can be retained in the chest causing Retained Blood Syndrome (RBS). Most of the time, chest tubes clot in the portion inside the patient, which is not addressable by clinicians. PleuraFlow® Active Clearance Technology™ enables caregivers to actively keep chest tubes clear of clot to maximize evacuation potential and decrease the potential for Retained Blood Syndrome.

After thoracic surgery, air, liquid, and blood can accumulate in the post surgical spaces around the heart and lungs, which can lead to complications and even death if not properly evacuated. Chest tubes are used to evacuate these collections, and are used in nearly all heart and lung surgery cases.
[About Retained Blood Complications...]

The PleuraFlow® Active Tube Clearance® System contains a guide wire with a distal loop that rests at the end of the tube. The system uses the loop to morcellate and scoop back clot towards the drainage canister. The system is driven by a proprietary magnetic drive to maintain a sterile environment within the tube. [How it Works...]

Contact ClearFlow

To learn more about innovative surgical products from ClearFlow, please contact us by email or phone.

ClearFlow Inc.
1630 S. Sunkist St., Suite E
Anaheim, CA 92806

Phone: +1-714-916-5010
or +1-844-CLR-FLOW (257-3569)

ClearFlow's PleuraFlow® Active Clearance Technology and many of its features are protected by a comprehensive family of both US and foreign patents and patent applications in major markets throughout the world, including Canada, Australia and the European Community. In the United States, PleuraFlow® products are protected by US Patent Nos. 7,854,728, 7,951,243, 8,246,752, 8,048,233, 8,388,759 and 8,702,662. The PleuraFlow® product is the first device of its kind to effectively and reproducibly clear obstructing material from chest tubes without compromising the sterile field, and thus patient recovery. It is the only FDA 510(k) cleared device of its kind for this indication. ClearFlow's patent portfolio has been tailored not only to protect this product, but also to provide protection around this new market segment thus presenting a barrier to entry for competing products.